Can I Take Vitamin D with Topical Minoxidil?
At a glance
- Minoxidil 5% solution / Over the counter, men only, vertex scalp [5][1]
- How it is applied / 1 mL twice daily to the hair-loss area [1]
- Vitamin D forms / D3 (cholecalciferol) and D2 (ergocalciferol) [6]
- Recommended intake / 600 IU a day to age 70; 800 IU after [7]
- Adult upper limit / 4,000 IU (100 mcg) a day [3]
- Vitamin D cautions / Thiazide diuretics, high blood calcium, kidney impairment, hyperparathyroidism [2][8][4]
- Bottom line / The dose limits and calcium cautions are vitamin D's
What topical minoxidil 5% does
Topical minoxidil 5% is an over-the-counter hair regrowth product applied to the scalp. The men's 5% solution is labeled for the top (vertex) of the scalp only and is not intended for frontal baldness or a receding hairline [1]. The 5% foam is also sold for women, once daily [9].
In cultured mouse hair follicles, minoxidil is converted to minoxidil sulfate, which was 14 times more potent than minoxidil in stimulating hair growth, and blocking the conversion stopped minoxidil from working [10]. A double-blind study of 16 volunteers found that 5% solution increased blood flow in the balding scalp within 15 minutes, and vital signs recorded over two days showed no systemic effect from the treatment [11]. The label says continued use is necessary to keep the regrowth, or hair loss will begin again [1].
Is there an interaction between vitamin D and topical minoxidil?
The two are handled in different places. Vitamin D taken by mouth is converted first in the liver to 25-hydroxyvitamin D, the form a blood test measures, and then in the kidney to the active hormone [2][7]. Topical minoxidil is applied to the scalp [1].
The minoxidil Drug Facts focus on scalp reactions, heart symptoms and what else is being put on the scalp, and they do not name vitamin D [1]. The vitamin D side is about dose and calcium [3][2].
Does vitamin D help hair grow?
The vitamin D receptor has a job in the hair cycle. A 2010 review in Dermatology Online Journal concluded that the receptor, independent of vitamin D itself, plays an important role in hair cycling, specifically anagen initiation, while the role of vitamin D in follicle cycling is less well understood [12].
The human data are observational. A 2013 study in Skin Pharmacology and Physiology measured serum vitamin D2 in 80 women aged 18 to 45 with hair loss and 40 age-matched women without it. Levels were lower in the women with chronic telogen effluvium (28.8 plus or minus 10.5 nmol/L) and female pattern hair loss (29.1 plus or minus 8.5 nmol/L) than in controls (118.2 plus or minus 68.1 nmol/L; P<0.001), and fell further with more severe disease [13]. Findings like these show an association, not a treatment effect.
The Endocrine Society's 2024 guideline states there is no clear evidence defining an optimal 25(OH)D target for disease prevention, and suggests against taking more than the recommended dietary allowance in healthy adults under 75 who have no established reason for vitamin D [6].
The vitamin D side: dose, calcium and diuretics
Vitamin D supplements are available in D3 (cholecalciferol) and D2 (ergocalciferol) forms [6]. The recommended dietary allowance is 600 IU (15 mcg) a day for ages 1 to 70, including pregnancy and lactation, and 800 IU (20 mcg) a day from age 71 [7]. The tolerable upper intake level for adults and teens 9 and older is 4,000 IU (100 mcg) a day, a ceiling rather than a target [3]. The Daily Value printed on supplement labels is 20 mcg, or 800 IU [14].
A meta-analysis of randomized trials found D3 raised serum 25(OH)D more than D2 overall (P=0.001), but the advantage came from single large doses and disappeared with daily supplementation [15].
Calcium is where vitamin D can bite. The prescription ergocalciferol label states that the range between therapeutic and toxic doses is narrow, and lists hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin D and hypervitaminosis D as contraindications [2]. A 25(OH)D above 150 ng/mL (375 nmol/L) is the hallmark of toxicity from overdosing, with symptoms of hypercalcemia such as confusion, vomiting, abdominal pain, polyuria and dehydration [16]. Documented cases have come from supplement manufacturing and labeling errors that delivered more than 1,000 times the labeled D3 dose [17].
Thiazide diuretics matter because they lower urinary calcium. In a post hoc analysis of a randomized trial of 328 Black adults given placebo or 1,000, 2,000 or 4,000 IU of D3 daily for three months, 84 hydrochlorothiazide users had serum calcium about 0.2 mg/dL higher than 44 participants not taking it (P<.001); one hydrochlorothiazide user had hypercalcemia and none in the comparison group did [4]. The ergocalciferol label also warns that thiazides given to hypoparathyroid patients taking it may cause hypercalcemia [2], and a systematic review says thiazides plus calcium and vitamin D supplements may cause hypercalcemia in the elderly or people with kidney impairment or hyperparathyroidism [8].
On testing: the Endocrine Society 2024 guideline suggests against routine 25(OH)D testing in the populations it reviewed [6], and the US Preventive Services Task Force found the evidence insufficient to weigh the benefits and harms of screening asymptomatic adults (I statement) [18].
What the minoxidil label asks you to watch
The OTC Drug Facts say the product is for external use only, and not to use it if the scalp is red, inflamed, infected, irritated or painful, or if you use other medicines on the scalp. The label lists heart disease among its warnings. It also says to stop use if chest pain, rapid heartbeat, faintness, dizziness, sudden unexplained weight gain, swelling of the hands or feet, scalp irritation or redness, or unwanted facial hair growth occurs [1][9].
The label line about other medicines on the scalp concerns products applied to the scalp [1]; a swallowed vitamin D supplement is not applied there.
If you take oral minoxidil instead
Minoxidil tablets are a prescription blood-pressure medicine, and no oral minoxidil product is FDA-approved for hair loss [19]. Low-dose oral use for hair loss is off-label. The oral tablet label names guanethidine as its only drug interaction. In a retrospective study of 1,404 patients treated for at least three months, hypertrichosis occurred in 15.1 percent, lightheadedness in 1.7 percent, fluid retention in 1.3 percent and tachycardia in 0.9 percent, and 1.2 percent stopped because of systemic effects [20].
Frequently asked questions
Can I take vitamin D with topical minoxidil?
How much vitamin D is reasonable alongside minoxidil?
Will vitamin D make minoxidil work better?
Do thiazide diuretics change anything if I take vitamin D?
Should I have a vitamin D blood test?
References
- U.S. National Library of Medicine, DailyMed. Men's Rogaine Extra Strength minoxidil 5% topical solution, Kenvue prescribing information. Men's Rogaine Extra Strength minoxidil 5% topical solution, Kenvue label
- U.S. National Library of Medicine, DailyMed. Ergocalciferol capsules (Rx) prescribing information. Ergocalciferol capsules (Rx) label
- The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know - PMC. The 2011 Report on Dietary Reference Intakes for Calcium and Vitamin D from the Institute of Medicine: What Clinicians Need to Know - PMC
- Chandler PD, Scott JB, Drake BF, Ng K, Forman JP, Chan AT, et al. Risk of hypercalcemia in blacks taking hydrochlorothiazide and vitamin D. Am J Med. 2014;127(8):772-8. Risk of hypercalcemia in blacks taking hydrochlorothiazide and vitamin D
- Drugs@FDA: FDA-Approved Drugs. Drugs@FDA: FDA-Approved Drugs
- Demay MB, Pittas AG, Bikle DD, Diab DL, Kiely ME, Lazaretti-Castro M, et al. Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2024;109(8):1907-1947. Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline
- Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53-8. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know
- Robien K, Oppeneer SJ, Kelly JA, Hamilton-Reeves JM. Drug-vitamin D interactions: a systematic review of the literature. Nutr Clin Pract. 2013;28(2):194-208. Drug-vitamin D interactions: a systematic review of the literature
- U.S. National Library of Medicine, DailyMed. Women's Rogaine minoxidil 5% topical foam, Kenvue prescribing information. Women's Rogaine minoxidil 5% topical foam, Kenvue label
- Buhl AE, Waldon DJ, Baker CA, Johnson GA. Minoxidil sulfate is the active metabolite that stimulates hair follicles. J Invest Dermatol. 1990;95(5):553-7. Minoxidil sulfate is the active metabolite that stimulates hair follicles
- Wester RC, Maibach HI, Guy RH, Novak E. Minoxidil stimulates cutaneous blood flow in human balding scalps: pharmacodynamics measured by laser Doppler velocimetry and photopulse plethysmography. J Invest Dermatol. 1984;82(5):515-7. Minoxidil stimulates cutaneous blood flow in human balding scalps: pharmacodynamics measured by laser Doppler velocimetry and photopulse plethysmography
- Amor KT, Rashid RM, Mirmirani P. Does D matter? The role of vitamin D in hair disorders and hair follicle cycling. Dermatol Online J. 2010;16(2):3. Does D matter? The role of vitamin D in hair disorders and hair follicle cycling
- Rasheed H, Mahgoub D, Hegazy R, El-Komy M, Abdel Hay R, Hamid MA, et al. Serum ferritin and vitamin d in female hair loss: do they play a role?. Skin Pharmacol Physiol. 2013;26(2):101-7. Serum ferritin and vitamin d in female hair loss: do they play a role?
- Daily Value on the Nutrition and Supplement Facts Labels | FDA. Daily Value on the Nutrition and Supplement Facts Labels | FDA
- Tripkovic L, Lambert H, Hart K, Smith CP, Bucca G, Penson S, et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr. 2012;95(6):1357-64. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis
- Marcinowska-Suchowierska E, Kupisz-Urbańska M, Łukaszkiewicz J, Płudowski P, Jones G. Vitamin D Toxicity-A Clinical Perspective. Front Endocrinol (Lausanne). 2018;9:550. Vitamin D Toxicity-A Clinical Perspective
- Araki T, Holick MF, Alfonso BD, Charlap E, Romero CM, Rizk D, et al. Vitamin D intoxication with severe hypercalcemia due to manufacturing and labeling errors of two dietary supplements made in the United States. J Clin Endocrinol Metab. 2011;96(12):3603-8. Vitamin D intoxication with severe hypercalcemia due to manufacturing and labeling errors of two dietary supplements made in the United States
- US Preventive Services Task Force, Krist AH, Davidson KW, Mangione CM, Cabana M, Caughey AB, et al. Screening for Vitamin D Deficiency in Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2021;325(14):1436-1442. Screening for Vitamin D Deficiency in Adults: US Preventive Services Task Force Recommendation Statement
- Drugs@FDA: FDA-Approved Drugs. Drugs@FDA: FDA-Approved Drugs
- Vañó-Galván S, Pirmez R, Hermosa-Gelbard A, Moreno-Arrones ÓM, Saceda-Corralo D, Rodrigues-Barata R, et al. Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients. J Am Acad Dermatol. 2021;84(6):1644-1651. Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients